Shamburg News · 8-K filed Nov 16, 2026, 4:00 PM EST
Metagenomi Therapeutics Furnishes November 2026 Corporate Presentation Under Regulation FD
MGX · Metagenomi Therapeutics, Inc.
- Reg FD disclosure
- Other event
- Materiality: low
Metagenomi Therapeutics, Inc. furnished its November 2026 corporate presentation as Exhibit 99.1 to this Form 8-K under Item 7.01, Regulation FD Disclosure. The filing states the information is furnished and not deemed filed under Section 18 of the Exchange Act. The presentation reports $101.7 million in cash, cash equivalents and available-for-sale marketable securities at end of Q3 2026, with runway anticipated into 2028.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001193125-26-463400.
Written from the filing by Shamburg Markets. Figures are as reported by the company.